Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells

Por Chen, Gang, Kronenberger, Peter, Teugels, Erik, De Grève, Jacques
Publicado em 2010

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

Por Chen Gang, Kronenberger Peter, Teugels Erik, Umelo Ijeoma, De Grève Jacques
Publicado em 2012-03-01

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

Por Chen, Gang, Kronenberger, Peter, Teugels, Erik, Umelo, Ijeoma Adaku, De Grève, Jacques
Publicado em 2012

Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

Por Chen, Gang, Noor, Alfiah, Kronenberger, Peter, Teugels, Erik, Umelo, Ijeoma Adaku, De Grève, Jacques
Publicado em 2013

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population

Por Stegel, Vida, Krajc, Mateja, Žgajnar, Janez, Teugels, Erik, De Grève, Jacques, Hočevar, Marko, Novaković, Srdjan
Publicado em 2011

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

Por Sermijn, Erica, Delesie, Liesbeth, Deschepper, Ellen, Pauwels, Ingrid, Bonduelle, Maryse, Teugels, Erik, De Grève, Jacques
Publicado no Fam Cancer (2016)

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers

Por Vermeij, Joanna, Teugels, Erik, Bourgain, Claire, Xiangming, Ji, in 't Veld, Peter, Ghislain, Vanessa, Neyns, Bart, De Grève, Jacques
Publicado em 2008

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families

Por Krajc, Mateja, Teugels, Erik, Zgajnar, Janez, Goelen, Guido, Besic, Nikola, Novakovic, Srdjan, Hocevar, Marko, De Grève, Jacques
Publicado em 2008

miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells

Por Chen, Gang, Umelo, Ijeoma Adaku, Lv, Shasha, Teugels, Erik, Fostier, Karel, Kronenberger, Peter, Dewaele, Alex, Sadones, Jan, Geers, Caroline, De Grève, Jacques
Publicado em 2013

Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer

Por Umelo, Ijeoma, Noeparast, Amir, Chen, Gang, Renard, Marleen, Geers, Caroline, Vansteenkiste, Johan, Giron, Philippe, De Wever, Olivier, Teugels, Erik, De Grève, Jacques
Publicado no Oncotarget (2015)

Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade

Por Umelo, Ijeoma Adaku, De Wever, Olivier, Kronenberger, Peter, Van Deun, Jan, Noor, Alfiah, Singh, Kshitiz, Teugels, Erik, Chen, Gang, Bracke, Marc, De Grève, Jacques
Publicado no Oncotarget (2015)

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasi...

Por De Grève, Jacques, Van Meerbeeck, Jan, Vansteenkiste, Johan F., Decoster, Lore, Meert, Anne-Pascale, Vuylsteke, Peter, Focan, Christian, Canon, Jean-Luc, Humblet, Yves, Berchem, Guy, Colinet, Benoit, Galdermans, Danny, Bosquée, Lionel, Vermeij, Joanna, Dewaele, Alex, Geers, Caroline, Schallier, Denis, Teugels, Erik
Publicado no PLoS One (2016)